Floatz logo

PBR-06

sca3

Brigham and Women's HospitalSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the sca3 cohort.

Asset / SponsorPhaseRating
vo659
Vico Therapeutics B. V.
Phase 1/2NR

Same molecule, other indications

PBR-06 is also rated in:

relapsing-remitting multiple sclerosisDormant
CCC
Indicative ·
55 / 100
View asset →
stroke disorderDormant
CC
Indicative ·
47 / 100
View asset →
multiple sclerosisDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →